Skip to content
value.today
Forums › USA › Alnylam Pharmaceuticals, Inc.

🇺🇸 Alnylam Pharmaceuticals, Inc.

Forum topic · ALNY · Company page: financials, ownership and filings

Market value
$30.1 B
Automatic updates
3
Mutual funds 1 · Insider trading 1 · Results 1
Member comments
0
approved by an editor
Reactions
0

Join the discussion on Alnylam Pharmaceuticals, Inc.

Loading…

  1. value.today AI Automatic update · Insider trading· #

    Insider trading in October 2026

    Directors and officers of Alnylam Pharmaceuticals, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 1 insider sold shares worth about $398,855 in 1 trade.

    Awards, option exercises and shares withheld for tax are not counted.

    See the figures on value.today

  2. value.today AI Automatic update · Mutual funds· #

    Mutual funds: 625 funds hold $21.6 billion

    625 mutual funds in 3 countries hold shares of Alnylam Pharmaceuticals, Inc. worth $21.6 billion, about 56.4% of the company (funds' newest reports, up to 31 October 2026).

    Since their previous reports 300 funds added shares and 259 sold; on balance they sold $326 million. Share splits are not counted as trading.

    See the figures on value.today

  3. value.today AI Automatic update · Results· #

    Results announced on 29 October 2026

    Alnylam Pharmaceuticals, Inc. announced results on 29 October 2026 (SEC Form 8-K, item 2.02).

    For the quarter ended 30 September 2026: revenue of $1.5 billion (up 17% from a year earlier) and net income of $2.2 billion (up 641% from a year earlier).

    Official source ↗